Dan Leonard
Stock Analyst at UBS
(2.44)
# 2,373
Out of 4,876 analysts
289
Total ratings
53.75%
Success rate
-6.15%
Average return
Main Sectors:
Stocks Rated by Dan Leonard
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MTD Mettler-Toledo International | Upgrades: Buy | $1,530 → $1,350 | $1,193.31 | +13.13% | 9 | May 20, 2025 | |
| TXG 10x Genomics | Maintains: Neutral | $14 → $12 | $11.70 | +2.56% | 5 | May 13, 2025 | |
| TECH Bio-Techne | Maintains: Buy | $95 → $70 | $52.80 | +32.58% | 11 | May 9, 2025 | |
| BRKR Bruker | Maintains: Neutral | $57 → $45 | $42.18 | +6.69% | 11 | May 8, 2025 | |
| IQV IQVIA Holdings | Maintains: Buy | $255 → $185 | $158.16 | +16.97% | 14 | May 7, 2025 | |
| BIO Bio-Rad Laboratories | Maintains: Buy | $355 → $310 | $243.47 | +27.33% | 20 | May 2, 2025 | |
| BIO.B Bio-Rad Laboratories | Maintains: Buy | $355 → $310 | $242.60 | +27.78% | 20 | May 2, 2025 | |
| GH Guardant Health | Maintains: Buy | $65 → $70 | $50.03 | +39.92% | 9 | May 1, 2025 | |
| RVTY Revvity | Upgrades: Buy | $145 → $115 | $98.79 | +16.41% | 2 | May 1, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Buy | $715 → $500 | $412.12 | +21.32% | 15 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $275 → $240 | $201.46 | +19.13% | 17 | Apr 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $29 → $25 | $13.74 | +81.95% | 7 | Jan 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $250 → $185 | $151.59 | +22.04% | 6 | Jan 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $7 → $9 | $7.29 | +23.46% | 2 | Oct 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $420 → $350 | $306.80 | +14.08% | 1 | Sep 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $16 | $11.42 | +40.11% | 9 | Sep 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $35 | $19.60 | +78.57% | 4 | Dec 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $160 → $150 | $119.42 | +25.61% | 21 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $225 → $200 | $94.16 | +112.40% | 16 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $14 → $11 | $2.38 | +362.18% | 6 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $70 | $168.17 | -58.38% | 7 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $75 → $90 | $51.81 | +73.71% | 9 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Underperform | $7 | $12.16 | -42.43% | 2 | Feb 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $345 | $354.91 | -2.79% | 12 | Aug 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $260 | $146.75 | +77.17% | 5 | Aug 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $160 → $145 | $177.06 | -18.11% | 10 | Feb 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $95 → $90 | $65.11 | +38.23% | 12 | Feb 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $62 → $64 | $48.04 | +32.49% | 3 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $330 → $340 | $256.98 | +32.31% | 11 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $24 | $25.09 | -4.34% | 1 | Aug 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $45 → $35 | $5.33 | +556.66% | 12 | Aug 14, 2019 |
Mettler-Toledo International
May 20, 2025
Upgrades: Buy
Price Target: $1,530 → $1,350
Current: $1,193.31
Upside: +13.13%
10x Genomics
May 13, 2025
Maintains: Neutral
Price Target: $14 → $12
Current: $11.70
Upside: +2.56%
Bio-Techne
May 9, 2025
Maintains: Buy
Price Target: $95 → $70
Current: $52.80
Upside: +32.58%
Bruker
May 8, 2025
Maintains: Neutral
Price Target: $57 → $45
Current: $42.18
Upside: +6.69%
IQVIA Holdings
May 7, 2025
Maintains: Buy
Price Target: $255 → $185
Current: $158.16
Upside: +16.97%
Bio-Rad Laboratories
May 2, 2025
Maintains: Buy
Price Target: $355 → $310
Current: $243.47
Upside: +27.33%
Bio-Rad Laboratories
May 2, 2025
Maintains: Buy
Price Target: $355 → $310
Current: $242.60
Upside: +27.78%
Guardant Health
May 1, 2025
Maintains: Buy
Price Target: $65 → $70
Current: $50.03
Upside: +39.92%
Revvity
May 1, 2025
Upgrades: Buy
Price Target: $145 → $115
Current: $98.79
Upside: +16.41%
Thermo Fisher Scientific
Apr 24, 2025
Maintains: Buy
Price Target: $715 → $500
Current: $412.12
Upside: +21.32%
Apr 23, 2025
Maintains: Buy
Price Target: $275 → $240
Current: $201.46
Upside: +19.13%
Jan 17, 2025
Downgrades: Neutral
Price Target: $29 → $25
Current: $13.74
Upside: +81.95%
Jan 17, 2025
Downgrades: Neutral
Price Target: $250 → $185
Current: $151.59
Upside: +22.04%
Oct 18, 2024
Maintains: Neutral
Price Target: $7 → $9
Current: $7.29
Upside: +23.46%
Sep 27, 2024
Downgrades: Neutral
Price Target: $420 → $350
Current: $306.80
Upside: +14.08%
Sep 27, 2024
Upgrades: Buy
Price Target: $16
Current: $11.42
Upside: +40.11%
Dec 7, 2023
Initiates: Neutral
Price Target: $35
Current: $19.60
Upside: +78.57%
Aug 16, 2023
Maintains: Outperform
Price Target: $160 → $150
Current: $119.42
Upside: +25.61%
Aug 10, 2023
Maintains: Neutral
Price Target: $225 → $200
Current: $94.16
Upside: +112.40%
Aug 8, 2023
Maintains: Neutral
Price Target: $14 → $11
Current: $2.38
Upside: +362.18%
Aug 4, 2023
Reiterates: Outperform
Price Target: $70
Current: $168.17
Upside: -58.38%
Aug 2, 2023
Maintains: Neutral
Price Target: $75 → $90
Current: $51.81
Upside: +73.71%
Feb 15, 2023
Reiterates: Underperform
Price Target: $7
Current: $12.16
Upside: -42.43%
Aug 25, 2022
Initiates: Neutral
Price Target: $345
Current: $354.91
Upside: -2.79%
Aug 25, 2022
Initiates: Neutral
Price Target: $260
Current: $146.75
Upside: +77.17%
Feb 4, 2022
Maintains: Equal-Weight
Price Target: $160 → $145
Current: $177.06
Upside: -18.11%
Feb 3, 2022
Maintains: Overweight
Price Target: $95 → $90
Current: $65.11
Upside: +38.23%
Dec 14, 2021
Maintains: Equal-Weight
Price Target: $62 → $64
Current: $48.04
Upside: +32.49%
Dec 14, 2021
Maintains: Overweight
Price Target: $330 → $340
Current: $256.98
Upside: +32.31%
Aug 10, 2021
Initiates: Overweight
Price Target: $24
Current: $25.09
Upside: -4.34%
Aug 14, 2019
Maintains: Hold
Price Target: $45 → $35
Current: $5.33
Upside: +556.66%